drug development for rare and neglected diseases and individualized therapies: workshop summary /
[edited by] Theresa Wizeman, Sally Robinson, and Robert Giffin ; Forum on Drug Discovery, Development, and Translation, Board on Health Services Policy, Institute of Medicine of the National Academies.
Introduction and overview -- Current model for financing drug development: from concept through approval -- The Food and Drug Administration's Orphan Drug Program -- Diverse funding models -- Strategies for facilitating sharing of research materials and data -- Strategies of navigation intellectual property -- Strategies for facilitating clinical trials -- Summary.
0
"The Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop on June 23, 2008, titled "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies." The purpose of the workshop was to explore innovative strategies for orphan drug development."
Breakthrough business models.
0309120888
Drug development for rare and neglected diseases and individualized therapies
Drugs-- United States-- Design.
Orphan drugs-- Government policy-- United States.
Pharmaceutical policy-- United States.
Models, Economic-- United States.
Orphan Drug Production-- economics-- United States.
Orphan Drug Production-- trends-- United States.
Research-- economics-- United States.
Research-- trends-- United States.
Drugs-- Design.
MEDICAL-- Allied Health Services-- General.
Orphan drugs-- Government policy.
Pharmaceutical policy.
United States.
7
MED-- 003000
362
.
17/820973
22
RA401
.
A3
B74
2009eb
2009
G-098
QV
736
W835b
2009
Giffin, Robert B.
Robinson, Sally.
Wizemann, Theresa M.
Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation.